Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M2YE
|
||||
Former ID |
DNAP001412
|
||||
Drug Name |
Lanreotide acetate
|
||||
Synonyms |
Somatuline lp (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Beaufour-Ipsen
|
||||
Structure |
Download2D MOL |
||||
Formula |
C54H69N11O10S2
|
||||
InChI |
InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)
|
||||
InChIKey |
PUDHBTGHUJUUFI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
4486252, 24897906, 43127689, 50054674, 50064235, 50125916, 50173040, 57318148, 85209139, 104350246, 125672970, 126682874, 127320088, 127320089, 127320090, 127320091, 127320092, 127320093, 127320094, 127320095, 127320096, 127320097, 127320098, 127320099, 127320100, 134222134, 134338678, 135029361, 135652022, 136101008, 137249412, 162224768, 163142465, 179294123, 223654400, 226420612, 239773461, 251971062
|
||||
SuperDrug ATC ID |
H01CB03
|
||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 2 | Target Info | Modulator | [532253] | |
References | |||||
Ref 532253 | Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors. Drugs Today (Barc). 2013 Feb;49(2):89-103. | ||||
Ref 539302 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2031). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.